Scandal-hit Fujiya picks new chief outside of founder clan

Scandal-hit Fujiya picks new chief outside of founder clan

TOKYO, Japan - Yasufumi Sakurai, new president of Fujiya Co., speaks during a news conference at a Tokyo hotel on Jan. 22. The confectionery maker faces a scandal involving the use of out-of-date ingredients in some of its cake products. Sakurai is the first president of Fujiya not related to the founding family.

  • Product Code
  • ILEA001120784
  • Registered date
  • 2007/1/22 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2007 Kyodo News
  • Media size
  • 1864 × 1228 pixel
  • Resolution
  • dpi
  • Deployment size
  • 452.62(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    JAL taps Tottori as 1st female president

    JAL taps Tottori as 1st female president

    Japan Airlines Co. President Yuji Akasaka (L) and senior managing executive officer Mitsuko Tottori, a former flight attendant, attend a press conference in Tokyo on Jan. 17, 2024. Tottori was named to become the company's first female president in April.
      JAL taps Tottori as 1st female president

      JAL taps Tottori as 1st female president

      Japan Airlines Co. President Yuji Akasaka (L) and senior managing executive officer Mitsuko Tottori, a former flight attendant, attend a press conference in Tokyo on Jan. 17, 2024. Tottori was named to become the company's first female president in April.
        JAL taps Tottori as 1st female president

        JAL taps Tottori as 1st female president

        Japan Airlines Co. President Yuji Akasaka (L) and senior managing executive officer Mitsuko Tottori, a former flight attendant, shake hands at a press conference in Tokyo on Jan. 17, 2024. Tottori was named to become the company's first female president in April.
          JAL president Akasaka

          JAL president Akasaka

          Japan Airlines Co. President Yuji Akasaka speaks at a press conference in Tokyo on Jan. 17, 2024.
            Daihatsu Motor president Okudaira

            Daihatsu Motor president Okudaira

            Daihatsu Motor Co. President Soichiro Okudaira meets the press at Japan's transport ministry in Tokyo on Jan. 16, 2024, over the automaker's improper safety testing scandal.
              Daihatsu Motor president Okudaira

              Daihatsu Motor president Okudaira

              Daihatsu Motor Co. President Soichiro Okudaira (R, back) meets the press at Japan's transport ministry in Tokyo on Jan. 16, 2024, over the automaker's improper safety testing scandal.
                Johnny's talent agency sex abuse scandal

                Johnny's talent agency sex abuse scandal

                Julie Keiko Fujishima speaks at a press conference in Tokyo on Sept. 7, 2023, after stepping down as president of Johnny & Associates Inc., one of Japan's most prominent talent agencies, amid allegations its late founder and her uncle Johnny Kitagawa had sexually abused teenagers aspiring to become pop singers for decades.
                  Johnny's talent agency sex abuse scandal

                  Johnny's talent agency sex abuse scandal

                  Julie Keiko Fujishima speaks at a press conference in Tokyo on Sept. 7, 2023, after stepping down as president of Johnny & Associates Inc., one of Japan's most prominent talent agencies, amid allegations its late founder and her uncle Johnny Kitagawa had sexually abused teenagers aspiring to become pop singers for decades.
                    Johnny's talent agency sex abuse scandal

                    Johnny's talent agency sex abuse scandal

                    Julie Keiko Fujishima speaks at a press conference in Tokyo on Sept. 7, 2023, after stepping down as president of Johnny & Associates Inc., one of Japan's most prominent talent agencies, amid allegations its late founder and her uncle Johnny Kitagawa had sexually abused teenagers aspiring to become pop singers for decades.
                      U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                      U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                      Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.